Results 201 to 210 of about 87,208 (292)

Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population‐based comparison

International Journal of Cancer, Volume 158, Issue 7, Page 1868-1880, 1 April 2026.
What's new? Marked differences in esophageal and gastric cancer survival rates exist between the Netherlands and Belgium, for reasons that remain unclear. In this study, the authors in‐vestigated these differences and attempted to identify contributing factors.
Benthe H. Doeve, Steven C. Kuijper, Geert Silversmit, Lien van Walle, Philippe Nafteux, Camiel Rosman, Pauline A. J. Vissers, Paul Jeene, Laurens V. Beerepoot, Sarah Derks, Amine Karimi, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven, Rob H. A. Verhoeven   +13 more
wiley   +1 more source

Three-Year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Neoadjuvant Chemoradiotherapy in Resectable Esophageal Cancer: A Multicenter Retrospective Study. [PDF]

Cancers (Basel)
Deng S, Yan X, Peng Y, Zhu L, Shen Y, Ying W, Xu Y, Fu Z.   +7 more
europepmc   +1 more source

Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real‐world matched comparison of overall survival

International Journal of Cancer, Volume 158, Issue 5, Page 1292-1301, 1 March 2026.
What's New? Patients with esophageal or gastroesophageal junction (GEJ) cancer with residual disease after treatment with neoadjuvant chemoradiotherapy (nCRT) and resection frequently experience poor survival. Improvements in outcome, however, may be possible using adjuvant treatment with nivolumab.
Rob H. A. Verhoeven, Steven C. Kuijper, Marije Slingerland, Bas Wijnhoven, Mark I. van Berge Henegouwen, Peter S. N. van Rossum, Sarah Derks, Bianca Mostert, Nadia Haj Mohammad, Hanneke W. M. van Laarhoven   +9 more
wiley   +1 more source

Correction: Impact of chemoradiotherapy for bladder cancer on pre-existing hydronephrosis and development of new hydronephrosis. [PDF]

Radiat Oncol
Remmelink MJ, El Awadly N, Arbeel-Weening B, Nadorp S, Leter MR, Oddens JR, Brück K, Nieuwenhuijzen JA, Bins AD.   +8 more
europepmc   +1 more source

EP-1107: Neoadjuvant chemoradiotherapy for the elderly patients with oesophageal carcinoma: a systematic review

, 2013
Q.N. Zhang, X.H. Wang, Z.G. Zhang
openalex   +1 more source

Aging‐Derived Alterations in Genomic, Immune, and Metabolic Networks: Implications for Cancer Development and Therapy

MedComm – Oncology, Volume 5, Issue 1, March 2026.
Ageing acts as a double‐edged sword in cancer. In the elderly, open chromatin, immunosenescence, and chronic inflammation drive SASP (IL‐6, MMPs), MDSC accumulation and T‐cell suppression, fostering tumor‐promoting microenvironments and limited therapeutic benefit.
Qi Wang, Xue Sun, Xinhao Han, Xingda Zhang, Wenzheng Wang, Hongbin Wang, He Ren, Lina Gu   +7 more
wiley   +1 more source

Clinical Trials Update in Resectable Esophageal Cancer. [PDF]

Cancers (Basel)
Dinerman AJ, Carr SR.
europepmc   +1 more source

Non‐Invasive, High‐Resolution (1H2O) Metabolic Activity Diffusion Imaging [MADI] of Rat Glioma

NMR in Biomedicine, Volume 39, Issue 3, March 2026.
We employed Metabolic Activity Diffusion Imaging [MADI] and 18FDG‐PET in rats with syngeneic RG2 glioblastoma brain tumors. MADI quantifies kio (the cellular H2O efflux rate constant), cell volume (V), and cell density (ρ), without the use of contrast agents. The kioV product quantifies the rate of water efflux per cell.
Joshua W. Schlegel, Samantha M. Holland, Felice D. Kelly, Eric M. Baker, Jared Stoller, William Packwood, Xin Li, Ramon F. Barajas Jr., Charles S. Springer Jr., Martin M. Pike   +9 more
wiley   +1 more source

Long-Term Survival Outcomes of NCRT With Surgery vs Surgery With Adjuvant Therapy for ESCC: A Single-Center Prospective Phase 3 Randomized Clinical Trial.

JAMA Netw Open
He W, Li Z, Xie Q, Han Y, Peng L, Wang C, Wang K, Liu G, Li H, Zhou Q, Li J, Zhang H, Xiao W, Fang Q, Miao Y, Leng X.   +15 more
europepmc   +1 more source

Multi‐omics predicts radiotherapy response in small cell lung cancer patients receiving whole brain irradiation

Journal of Applied Clinical Medical Physics, Volume 27, Issue 2, February 2026.
Abstract Objective Dosiomics and radiomics elaborate the low‐and high‐order features extracted from images to predict clinical outcomes. Whole‐brain radiotherapy (WBRT) has been widely used in patients with diffuse brain metastases of small cell lung cancer (SCLC).
Yifan Lei, Han Bai, Chengshu Gong, Yaoxiong Xia, Yu Hou, Ruiling Yang, Jinhui Yu, Zhe Zhang, Li Wang, Bo Li, Li Wang, Lan Li   +11 more
wiley   +1 more source